The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Keenan Greg since 2025.
This trader's CIK number is 2044006.
At the time of last reporting, Keenan Greg was the Chief Medical Officer of Aurinia Pharmaceuticals Inc.. (stock ticker symbol AUPH).
Also see all insider trading activities at Aurinia Pharmaceuticals Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | AUPH | 0 | $0 | 40,544 | $376,262 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-01 | AUPH | Sale | 20,000 | 10.50 | 210,000 |
| 2025-03-07 | AUPH | Sale | 8,305 | 8.23 | 68,350 |
| 2025-03-03 | AUPH | Sale | 12,239 | 8.00 | 97,912 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Keenan Greg (Chief Medical Officer of Aurinia Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.